An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.
|Articles|July 17, 2023
News Roundup: July 10 to July 16
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
AI Streamlines Pharmacy Workflow
Artificial intelligence can be a key tool for streamlining pharmacy workflows.
NJ Governor Phil Murphy Signs PBM, Drug Price Legislation
Three new bills signed Monday will require PBMs to use prescription drug rebates to lower premiums and out-of-pocket costs for consumers and prevent the practice of spread pricing.
Many Patients With COPD Have Poor Adherence to Long-Acting Inhalers
Researchers encourage physicians to personalize care plans to ensure that more patients adhere to their inhalers.
Study Explores Link Between Chronic Viral Infections and Long COVID
Underlying HIV infection was independently associated with neurocognitive long COVID symptoms.
Can Post-Exposure Doxycycline Prevent Sexually Transmitted Infections?
A study examined STI rates following doxycycline post-exposure prophylaxis to see if it could reduce infection rates.
Advertisement
Related to this article
Matthew Crawford, PhD, of the University of Virginia, and Mario Danek of Qnovia explain what pharmacists can do now and what may come next.
The inquiry puts audit practices, including how pharmacies are selected for audit, proportionality, and pharmacy advocacy in focus.
Nolla Derm’s overseeing physician, Zaid Fadul, MD, FS, FAAFP, discusses the revolutionary AI technology that could transform how health care conducts prescribing practices.
As COVID-19 vaccine guidance shifts, new data suggest vaccinated patients face no greater clot or death risk than with other respiratory infections.
Alyssa Eisenberg, PharmD, explores technology’s emerging role in the health care environment and how the pharmacist of the future’s day-to-day tasks might evolve.
In the final portion of our discussion with Kimberly Kue-Tsemo, PharmD, she explores the key developments that could be the most significant push toward reducing pharmacy deserts.
In the second part of our interview with a collection of pharmacists from various backgrounds, they delve into the current developments highlighting the future of the profession.
Advertisement
Advertisement
Trending on Drug Topics
1
PBM Audit Practices Under Scrutiny: What the House Inquiry Means for Independent Pharmacies
2
GLP-1s Outperform Metformin in Prediabetes Risk, MACE
3
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
4
The Uncounted Threat: Antibiotic-Resistant Pneumonia
5